Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer.
about
Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancerMicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate CancerSmall Non-coding Transfer RNA-Derived RNA Fragments (tRFs): Their Biogenesis, Function and Implication in Human DiseasesBeyond the Ribosome: Extra-translational Functions of tRNA FragmentsNon-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer MetabolismGenome-wide analysis of microRNA and mRNA expression signatures in cancertRNA fragments in human health and diseaseThe mutational landscape of prostate cancerSmall RNAs with big implications: new insights into H/ACA snoRNA function and their role in human diseaseA Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside PotentialLong Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical TranslationGenomic-Wide Analysis with Microarrays in Human OncologyDecreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in miceA novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapyBioinformatics of Cancer ncRNA in High Throughput Sequencing: Present State and ChallengesGenomic sequencing in clinical trialsmiRNAs associated with prostate cancer risk and progressionmiRDeep*: an integrated application tool for miRNA identification from RNA sequencing data.MicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samplesDistinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancerNoncoding RNAs in endocrine malignancyNew frontiers in translational control of the cancer genomeNoncoding RNAs as novel biomarkers in prostate cancer.Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma.Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer.The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells.Expression of lysophosphatidic acid receptor 1 and relation with cell proliferation, apoptosis, and angiogenesis on preneoplastic changes induced by cadmium chloride in the rat ventral prostateNon-Coding RNAs: Functional Aspects and Diagnostic Utility in OncologyCoordinate microRNA-mediated regulation of protein complexes in prostate cancer.Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs.Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis.snoRNAs are a novel class of biologically relevant Myc targets.A central role for long non-coding RNA in cancerGenomic "Dark Matter" in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers.Correlation of Global MicroRNA Expression With Basal Cell Carcinoma Subtype.Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer.MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer.
P2860
Q21133676-0DAB1326-B35A-4C45-8C9A-EA506F90624BQ26751983-EBFC6057-F32D-4E9C-A876-BCA10B673DE9Q26766672-858E0077-9E15-4EC2-A09E-18AF780CC08AQ26769608-6A9B6276-EC8C-45B7-A619-FA1C405BA6A3Q26774456-FA3B4F9F-6D23-4099-BC56-11A751EE664AQ26795603-414D8F97-BC7D-4722-99AB-E5A9760896E9Q26824181-EF6BE9A5-56A4-4E1F-9CA9-DEDC0ECC5D42Q26851631-DCA9F992-44A4-4FC6-8F03-CC9F5658938CQ27016076-DD1324CF-D4FA-4CC3-BD31-7122AC68DF3CQ27022638-08FF3B2E-3228-45EC-B538-3BC8944340D1Q28071872-1AB7AA06-D934-460C-A808-446419C8476CQ28081059-108F4E90-3190-4EC7-B614-CC6202298B3CQ28118790-63A3D177-743C-47B8-856B-926299F0DADBQ28543958-B8201EED-A7CB-4ECE-A882-374A625CD93FQ28710308-9C152C8A-FA66-488B-A514-6F858F4BDE01Q28732333-D99ABE53-35EA-479C-942B-D59BEA06051DQ30235186-23765F9E-E28E-468B-9AC6-B29F431AC772Q30580665-29B3CF99-B11C-46BF-AE26-F9D6D2FF2A15Q30859743-82B01DC6-9575-46CF-B0F4-431981B6E755Q31119968-2DC4A747-71A9-451C-A036-DCBAE66E4CA2Q33577889-1310025E-563B-4638-8D06-57A293E777A9Q33853235-EC68A676-2EC5-4664-BB20-FABA353B1B47Q34176890-CF86031B-246C-4F74-AE0C-A98EF1B25749Q34248844-5AA945BA-A76B-4899-9F4C-F86A06BBC70BQ34354560-FA73D4D5-FB12-443C-9632-6FA1200E6150Q34489344-7C5AD628-A2A7-4144-B143-0B9A0598E3BDQ34540405-BA13F52E-7320-4112-AEEC-C25638508CB7Q34603802-6F8EAB48-10A1-48E8-81CC-F3E9C674B4A0Q34605730-12A6A001-34DF-4A6C-A241-1EE61F93ACF6Q35082892-34D1FC3D-0A91-496A-BF6F-BB7186AC1F4AQ35092050-48985F58-AF66-4A22-82DD-C68DA761F86DQ35110766-1A66AEFA-6758-4860-AB5A-386F70B00CFBQ35544302-2505C0CD-C61F-4337-A93A-2A09A4A9890DQ35573029-4054F958-A27D-41CD-AAC7-A4071EBB0058Q35604143-DB69B104-54C7-447A-B39C-EEEAB85876D9Q35757646-08EFD2C2-2522-4A4C-BD75-D8F622CE9A9BQ35771477-07124F61-8BB8-4C69-8036-2CA969DCA084Q35771697-D8AB528E-7011-4A0B-9BD4-9931A4EF7D35Q35814277-F117D436-5187-4CCC-944A-39C4102CD4E7Q35906143-FBDB6A28-7051-48DF-9F40-61B3C5FD42D1
P2860
Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Diagnostic and prognostic sign ...... nscriptome in prostate cancer.
@en
Diagnostic and prognostic sign ...... nscriptome in prostate cancer.
@nl
type
label
Diagnostic and prognostic sign ...... nscriptome in prostate cancer.
@en
Diagnostic and prognostic sign ...... nscriptome in prostate cancer.
@nl
prefLabel
Diagnostic and prognostic sign ...... nscriptome in prostate cancer.
@en
Diagnostic and prognostic sign ...... nscriptome in prostate cancer.
@nl
P2093
P2860
P921
P356
P1433
P1476
Diagnostic and prognostic sign ...... nscriptome in prostate cancer.
@en
P2093
C H Bangma
E S Martens-Uzunova
G J L H van Leenders
S E Jalava
T Visakorpi
P2860
P2888
P304
P356
10.1038/ONC.2011.304
P407
P577
2011-07-18T00:00:00Z
P5875
P6179
1045154711